Latest filing published 02 Oct 2026 for Ingevity Corp, €25k. Read the official filing
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
J. Kevin Willis, listed as finance chief, has filed trades across 5 companies (mainly through SEC (Form 4)), most often in Ashland Inc., Ingevity Corp and Ashland Global Holdings Inc. We count 44 filings; the first trade dates from 4 January 2016 and the latest from 1 October 2026.
The open-market side counts 4 purchases for €656k alongside 1 sale for €88k. The net balance comes to €568k on the buying side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 20 share grants and 18 option exercises. 2026 to date brings 1 purchase and no sales.
The median purchase comes to €180k. Of 4 purchases, 1 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. Looking at 3 purchases old enough to measure, the stock rose over the following 90 days in 67% of cases; the median change was +2.9%. They describe history only and say nothing certain about the share price ahead.
Most recently, on 2 October 2026, the filings show a share grant worth €25k in Ingevity Corp. The last insider purchase was made public on 15 May 2026, 156 days ago. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 44 declarations